Core Views - The article discusses the contrasting strategies of two major beauty groups, L'Oréal and Unilever, highlighting L'Oréal's aggressive acquisition approach and Unilever's focus on divesting non-core assets [2][8]. Group 1: L'Oréal's Acquisition Strategy - L'Oréal announced the acquisition of an additional 10% stake in Galderma, increasing its ownership from 10% to 20%, with plans to explore further scientific research collaborations [1][6]. - The acquisition is part of L'Oréal's ambition to penetrate the rapidly growing medical aesthetics market, alongside its investments in high-end and clean beauty segments [6][8]. - In October, L'Oréal made a significant investment of €4 billion to acquire beauty licenses from Kering Group, indicating a strong recovery in its performance, particularly in the North Asia region [6][7]. Group 2: Unilever's Divestment Strategy - Unilever is undergoing a restructuring process, focusing on core businesses by divesting over 20 non-core beauty and personal care brands, including the planned spin-off of its ice cream business [1][7]. - The CEO of Unilever emphasized that the spin-off aims to create a more streamlined company focused on higher profit margins in beauty and personal care sectors [7][8]. - Unilever's recent quarterly results showed improvement in sales growth after excluding the ice cream business, indicating a positive trend in its core operations [7][8]. Group 3: Industry Trends and Brand Matrix - The contrasting strategies of L'Oréal and Unilever reflect a broader industry trend where companies are either expanding their brand portfolios or optimizing them by shedding non-core assets [8][9]. - The ideal brand matrix should exhibit strategic synergy, growth gradient, and profit orientation, allowing companies to withstand market fluctuations [10]. - Other beauty brands, including Estée Lauder, are also reviewing their brand portfolios, indicating a shift towards optimizing brand performance and profitability [9].

12月8日，两大美妆集团做起了"加减法"。 一则是欧莱雅集团宣布将从EQT等领导的财团手中收购丝塔芙母公司高德美（Galderma）10%的股份。 由此，欧莱雅集团在高德美的持股比例从10%增至20%。 "美学是我们核心美容业务的一个重要邻近领域，我们热衷于继续探索。"欧莱雅首席执行官叶鸿慕表 示，"我们在2024年对高德美的初步战略投资非常成功，因此我们渴望巩固并进一步扩展合作关系。" 另一则是梦龙冰淇淋公司（The Magnum Ice Cream Company N.V.）宣布其普通股于荷兰、英国、美国 三地正式上市交易。此举标志着联合利华冰淇淋业务分拆工作基本完成。 高德美在公告中表示，其和欧莱雅还计划探索更多共同感兴趣的科学研究项目。"我们对欧莱雅的增资 感到欣慰，这肯定了我们的发展方向，并预示着未来几年我们将创造更高的价值。"高德美首席执行官 Flemming Rnskov表示，"进入2026年，我们仍将全力专注于我们的整体皮肤学战略。" 而欧莱雅在官宣消息中提到，"此次收购高德美额外10%的股份，实际上是重申了欧莱雅进军快速增长 的医美市场的雄心"。事实上，不仅是对医美市场，对高端美妆、纯净美妆 ...